If you've gone looking for the "right" amount of NMN, you've probably found numbers scattered from 250 mg to well over 1,000 mg a day — often stated with a confidence the science doesn't quite support. Here's the honest version: in published human studies, NMN has most often been taken at about 250 to 900 mg per day, and a couple of short safety studies went as high as 1,250 mg. There is no official recommended dose, because NMN is a supplement, not a medication.
Below is what the actual trials used, why "more" isn't automatically "better," when people tend to take it, and the honest limits of what a number on a label can tell you. If NMN is new to you, it's worth a two-minute detour through what NMN actually is → first.
Is there a recommended NMN dosage?
Not in the official sense. NMN doesn't have a Recommended Dietary Allowance, and the FDA doesn't set dosing guidance for supplements the way it does for drugs. So when a label or a blog gives you a firm "take this much," that figure is drawn from what researchers happened to use in trials — not from a regulatory standard or a proven optimal number.
What we can do is look at the doses that have actually been studied in people, note how they were tolerated, and be honest about where the evidence stops. That's a more useful starting point than a made-up precise number, and it's the right conversation to have with your own clinician.
How much NMN do studies actually use?
Most human trials have landed in a fairly narrow band. A 2023 dose-ranging trial in healthy middle-aged adults compared 300, 600, and 900 mg a day for 60 days; a 2021 study in postmenopausal women used 250 mg a day for 10 weeks; a study in recreational runners tested 300, 600, and 1,200 mg; and a short safety study gave 1,250 mg once daily for four weeks. Here's the map:
| Daily amount | Where it shows up in the research |
|---|---|
| 250 mg | Used for 10 weeks in postmenopausal women; reported as well tolerated. |
| 300 mg | The lower arm of two dose-ranging trials; raised blood NAD⁺ levels versus placebo. |
| 600 mg | The point where blood NAD⁺ and a walking-endurance test peaked in the 2023 dose-ranging trial. |
| 900 mg | Well tolerated in the same trial — without much added benefit over 600 mg on those measures. |
| 1,200–1,250 mg | Used in shorter performance and safety studies; still reported as well tolerated. |
Two things stand out. First, the 250–900 mg range covers the large majority of the research. Second, across these trials NMN was consistently described as well tolerated, with side effects that were mild and generally similar to placebo — a point we cover in more depth in our overview of choosing an NMN supplement →.
Is more NMN better?
Not necessarily — and this is the part the marketing tends to skip. In the 2023 dose-ranging trial, blood NAD⁺ and physical-performance measures improved at every dose, but they peaked around 600 mg a day; the 900 mg group didn't show a meaningful additional gain on those endpoints. In plain terms, the response appeared to flatten out rather than climb steadily with every extra milligram.
That's a useful reality check. A bigger number on the label isn't automatically a bigger effect, and it usually means a higher price and a faster-emptying jar. The studied range gives you context; it doesn't crown a single "best" dose.
Should you dose NMN by age or body weight?
You'll see charts online that assign a tidy NMN dose to each age bracket — more at 50 than at 40, more again at 60. It's a neat idea, but the human trials weren't designed that way, and there's no published evidence base for an age-scaled dosing chart. The dose-ranging studies gave the same amounts to everyone in a group and compared results; they didn't tailor a number to a birthday.
Body weight is a slightly different story: it's a plausible variable, and a few researchers have discussed scaling loosely by it, but there's still no validated formula that says "X mg per kilogram." So treat age-and-weight dosing tables as marketing structure, not science. The honest summary is that studies used fixed amounts in the 250–900 mg range regardless of age.
When should you take NMN — morning or night, with food?
Most trials had participants take NMN in the morning, and that's the convention most people follow — the reasoning being that NAD⁺ metabolism tracks your daily activity cycle, so morning fits the body's natural rhythm. That said, timing has not been rigorously compared head-to-head for outcomes, so "morning is best" is a reasonable habit rather than a proven rule.
On food: NMN has been taken both with and without meals in studies, and it's water-soluble, so there's no strong requirement either way. The most practical advice is unglamorous — pick a time you'll actually remember every day. Consistency matters more than the clock, which is exactly why so many people quietly stop taking NMN → before they've given it a fair run.
How much NMN is in CELLSHE NMN 500?
CELLSHE NMN 500 → provides 500 mg of NMN per daily serving — squarely inside the range used across the human studies above, and close to the 600 mg point where the dose-ranging data leveled off. It's formulated to support cellular energy production* and to support NAD⁺ biosynthesis* as part of a steady daily routine, not a mega-dose you have to keep chasing upward.
If you're comparing products, the number that matters is the actual NMN per serving, alongside third-party testing and a transparent label — the criteria we walk through in our guide to the best NMN supplements →. A clean 500 mg you take every day is worth more than a bigger number you abandon in a month.
What an NMN dosage will not do
A dose is a starting point, not a promise. Even at the amounts used in studies, NMN will not reverse aging, undo the years, or guarantee a particular result — the human research is still young, mostly short-term, and measured in biomarkers and performance tests rather than long lives. It is not a treatment for any medical condition, and no supplement dose replaces sleep, movement, or your doctor's advice.
If you take medication, are pregnant or nursing, or manage a health condition, talk with your clinician before starting NMN — that's the single most useful thing you can do with a dosing question. Approached honestly, NMN is a well-studied ingredient you take consistently at a sensible amount, not a dial you crank for a bigger effect.
Frequently asked questions
How much NMN should a beginner take?
There's no official beginner dose. Many people start at the lower end of the studied range — around 250 to 500 mg a day — simply because it's the amount most trials used and it's easy to keep consistent. It's a good question to run past your clinician, especially if you take other medications.
Can you take too much NMN?
Human studies up to 900 mg a day, and short safety studies at 1,250 mg, reported NMN as well tolerated, with mostly mild effects. But "well tolerated in a trial" isn't the same as "more is better," and long-term data at high doses is limited — which is why chasing ever-larger amounts isn't supported by the evidence.
Is 1,000 mg of NMN too much?
It's above the point where benefits appeared to level off in the dose-ranging research, though amounts in that neighborhood have been used in studies without serious adverse events reported. More isn't automatically better, so a higher number is worth questioning rather than assuming.
Does NMN dosage depend on your weight?
Possibly in theory, but there's no validated weight-based formula. Trials used fixed amounts (commonly 250–900 mg) rather than dosing per kilogram, so weight-based charts are more marketing than science at this point.
How long does NMN take to show anything?
Studies ran from a few weeks to a couple of months before measuring changes in blood NAD⁺ or performance, so this is a consistency game, not an overnight one. Pick a dose in the studied range, take it daily, and give it a fair, uninterrupted run.
References
- Yi L, et al. (2023). The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial. GeroScience. 45(1):29–43. PMID: 36482258. pubmed.ncbi.nlm.nih.gov/36482258
- Fukamizu Y, et al. (2022). Safety evaluation of β-nicotinamide mononucleotide oral administration in healthy adult men and women. Scientific Reports. 12:14442. PMID: 36002548. pubmed.ncbi.nlm.nih.gov/36002548
- Liao B, et al. (2021). Nicotinamide mononucleotide supplementation enhances aerobic capacity in amateur runners: a randomized, double-blind study. Journal of the International Society of Sports Nutrition. 18(1):54. pmc.ncbi.nlm.nih.gov/PMC8265078
- Yoshino M, et al. (2021). Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women. Science. 372(6547):1224–1229. PMID: 33888596. pubmed.ncbi.nlm.nih.gov/33888596
